Galmed Pharmaceuticals (GLMD) EBT Margin (QoQ) (2016 - 2018)
Galmed Pharmaceuticals (GLMD) EBT Margin (QoQ) (2016 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.65 Bn | 131.79 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.08 Bn | 78.09 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn |
| 4 | Moderna | 63.25 Bn | 58.11 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.26 Bn | 27.95 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.96 Bn | 10.57 Bn | 668.28 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.35 Bn | - |
| 10 | Galmed Pharmaceuticals | 2.39 Mn | -9.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 6,153.00 |
| Jun 30, 2018 | -1,341.00 |
| Mar 31, 2018 | -131,911.00 |
| Dec 31, 2017 | 30,392.00 |
| Sep 30, 2017 | 2,897.00 |
| Jun 30, 2017 | -18,804.00 |
| Mar 31, 2017 | -57,624.00 |
| Dec 31, 2016 | -16,977.00 |